Prospective partners with the most attractive projects are expected to enhance and expand business potential and scope for uterine cancer therapy globally. Marketers are developing and designing in-licensing and out-licensing strategies based on the identification of emerging players with potentially strong product portfolio. They are also designing effective counter-strategies to gain competitive advantage. Visit : http://www.researchonglobalmarkets.com/uterine-cancer-pipeline-review-h2-2013.html